EUVIMEDEUVIMED entdecken
Crossref

Cellular hypoxia reprograms drug response and reveals curcumin-driven cancer stem-cell-associated marker enrichment in oral squamous cell carcinoma

Hazar S Alharbi, Ishrat Rahman, Manal A AlSheddi, Hanan Henidi, Manal Mubarak Alkahtani, Zaha Al Makhlafi, Sahar ElRefai, Shams A Altwaim, Hourya Sanat Alnofaie, Hend M Salem, Maha Galal Omar, Alia Alturki und 9 weitere

World Journal of Stem Cells · 26.08.2026 · 18 (8)

DOI: 10.4252/wjsc.121991 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Stem Cells, online erschienen am 26.08.2026. Verfasst von Hazar S Alharbi und 20 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Oral squamous cell carcinoma is a deadly cancer often detected late, contributing to high mortality and treatment failure. The efficacy of first-line chemotherapeutic agents is limited by resistance and a narrow therapeutic index. Naturally derived compounds, including curcumin, are increasingly being explored for their anti-inflammatory and anticancer potential. AIM To determine whether curcumin retains cytotoxicity under hypoxia compared with carboplatin and assess apoptosis, reactive oxygen species (ROS), and stemness markers. METHODS The OECM-1 model of late-stage cancer cultured under hypoxic conditions was validated by measuring hypoxia-induced factor 1 alpha levels using enzyme-linked immunosorbent assay. Drug cytotoxicity was measured using the MTT assay. Oxidative stress was assessed using a DCFDA cellular ROS assay; apoptosis was determined using Annexin V staining; and surface cancer stem cell (CSC) markers were detected using flow cytometry with antibodies against CD44, CD133, and CD147. Dose-response curves were analyzed using nonlinear regression, and drug interactions were assessed using exploratory CI, Bliss, and Highest Single Agent analyses. RESULTS Hypoxia-induced factor 1 alpha levels were six-fold higher under hypoxia than normoxia (P = 0.0032). Curcumin retained cytotoxic activity under hypoxia, whereas carboplatin potency and efficacy declined. Combining carboplatin with curcumin reduced curcumin potency under hypoxia and did not show synergy by exploratory CI, Bliss, or Highest Single Agent analyses. Carboplatin did not significantly alter ROS levels, whereas curcumin alone or in combination with carboplatin reduced ROS under normoxia and hypoxia (P = 0.039 to P < 0.0001). Treatments did not induce apoptosis under normoxia but increased apoptosis under hypoxia. Carboplatin did not alter the expression of CD44, CD133, or CD147 in either model, whereas curcumin and the combined treatment increased the expression of CSC-associated markers, particularly CD44+CD133+ under hypoxia (P < 0.0001). CONCLUSION Curcumin retained cytotoxic activity in a hypoxic, chemoresistant late-stage model where carboplatin activity declined, but increased CSC-associated marker expression, requiring functional validation.

Zitieren

APA

Alharbi, H. S., Rahman, I., AlSheddi, M. A., Henidi, H., Alkahtani, M. M., Makhlafi, Z. A., ElRefai, S., Altwaim, S. A., Alnofaie, H. S., Salem, H. M., Omar, M. G., Alturki, A., Talic, H., Aladhyani, G., Alotaibi, F., Basuhail, H., Alotaibi, R., Alturki, N., Alharbi, A., …, & Albassam, S. K. (2026). Cellular hypoxia reprograms drug response and reveals curcumin-driven cancer stem-cell-associated marker enrichment in oral squamous cell carcinoma. World Journal of Stem Cells, 18(8). https://doi.org/10.4252/wjsc.121991

Vancouver

Alharbi HS, Rahman I, AlSheddi MA, Henidi H, Alkahtani MM, Makhlafi ZA, et al. Cellular hypoxia reprograms drug response and reveals curcumin-driven cancer stem-cell-associated marker enrichment in oral squamous cell carcinoma. World Journal of Stem Cells. 2026;18(8). doi:10.4252/wjsc.121991

BibTeX
@article{Alharbi2026,
  author = {Alharbi, Hazar S and Rahman, Ishrat and AlSheddi, Manal A and Henidi, Hanan and Alkahtani, Manal Mubarak and Makhlafi, Zaha Al and ElRefai, Sahar and Altwaim, Shams A and Alnofaie, Hourya Sanat and Salem, Hend M and Omar, Maha Galal and Alturki, Alia and Talic, Hiba and Aladhyani, Ghada and Alotaibi, Fotoon and Basuhail, Hadeel and Alotaibi, Rasil and Alturki, Nada and Alharbi, Aljawhara and Alsultan, Rafa and Albassam, Sara Khalid},
  title = {Cellular hypoxia reprograms drug response and reveals curcumin-driven cancer stem-cell-associated marker enrichment in oral squamous cell carcinoma},
  journal = {World Journal of Stem Cells},
  year = {2026},
  volume = {18},
  number = {8},
  doi = {10.4252/wjsc.121991}
}
Kostenlos starten →